Abstract
To determine the impact of a strategy using enoxaparin for up to 8 days compared with unfractionated heparin (UFH) for 48 h as an adjunct to fibrinolysis for ST-segment elevation myocardial infarction (STEMI) on 1-year clinical outcomes.
| Original language | English |
|---|---|
| Pages (from-to) | 2097-102 |
| Number of pages | 6 |
| Journal | European Heart Journal |
| Volume | 31 |
| Issue number | 17 |
| DOIs | |
| Publication status | Published - 2010 |
Keywords / Materials (for Non-textual outputs)
- Enoxaparin
- Heparin
- Anti-thrombin
- Myocardial infarction
- Fibrinolysis
Fingerprint
Dive into the research topics of 'One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver